ALEXION PHARMACEUTICALS INC·4

Mar 6, 6:03 PM ET

ALEXION PHARMACEUTICALS INC 4

4 · ALEXION PHARMACEUTICALS INC · Filed Mar 6, 2017

Insider Transaction Report

Form 4
Period: 2017-02-28
Thiel Carsten
SVP, EMEA & Asia Pacific
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2017-02-28$131.01/sh3,783$495,61133,860 total
Footnotes (2)
  • [F1]The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.70 - $131.69. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_148884141474383.xmlPrimary

    FORM 4